← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 30, 2015Last known activity
Jan 1, 2018
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT03475121CollaboratorPhase 3Jan 1, 2018
- NCT03400709Reponsible party - principal investigatorN/ANov 30, 2015
- NCT03400709Lead sponsorN/ANov 30, 2015
Details
- Last known activity
- Jan 1, 2018